Stay updated on Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision label has been updated from v3.5.3 to v3.5.4, indicating a small maintenance update to the page metadata rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-05-15T02:06:27.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3, indicating a new build of the page in the revision history. This change is a metadata update with no impact on user-facing information.
    Difference
    0.1%
    Check dated 2026-04-30T15:50:04.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 as part of the site version update.
    Difference
    0.1%
    Check dated 2026-04-16T10:57:19.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed from the page. This is a metadata update that does not modify study details.
    Difference
    0.1%
    Check dated 2026-03-18T18:06:30.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:51:36.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The funding-lapse notice and the prior revision (v3.4.1) were removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:10:11.000Z thumbnail image

Stay in the know with updates to Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.